- In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models
- Preparation and Biological Evaluation of Copper-64Labeled Tyr3 Octreotate Using a Cross-Bridged Macrocyclic Chelator
- In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands
- Evaluation of Radiolabeled Type IV Collagen Fragments as Potential Tumor Imaging Agents
- In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
- Labeling and in Vivo Evaluation of Novel Copper(II) Dioxotetraazamacrocyclic Complexes
- In Vitro and In Vivo Evaluation of 64 Cu-TETA-Tyr3
- Radiopharmaceuticals for Positron Emission Tomography Imaging of Somatostatin Receptor
- A Potential DubinJohnson Syndrome Imaging Agent: Synthesis, Biodistribution, and MicroPET Imaging
- 64Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- Copyright 2005 John Wiley & Sons, Ltd. Biomed. Chromatogr. 20: 3747 (2006) Investigation of copperazamacrocyclic complexes 37ORIGINAL RESEARCHORIGINAL RESEARCH
- [CANCER RESEARCH 63, 68646869, October 15, 2003] Subcellular Localization of Radiolabeled Somatostatin Analogues: Implications for
- DOTA-D-Tyr1-Octreotate: A Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and
- Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS
- Synthesis and Characterization of a Macrocyclic Near-Infrared Optical Yunpeng Ye, Wen Ping Li, Carolyn J. Anderson, Jeffery Kao, Gregory V. Nikiforovich, and
- Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands
- CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 16, Number 6, 2001
- CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 16, Number 6, 2001
- Radiotherapy and Dosimetry of 64 Cu-TETA-Tyr3
- Evaluation of Gallium-68 Tris(2-Mercaptobenzyl)Amine: A Complex with Brain and Myocardial Uptake
- Identification of the Soluble in Vivo Metabolites of Indium-111-Diethylenetriaminepentaacetic Acid-D-Phe1-Octreotide
- Proc. Natl. Acad. Sci. USA Vol. 93, pp. 68146818, June 1996
- N,N-Ethylenedi-L-cysteine (EC) and Its Metal Complexes: Synthesis, Characterization, Crystal Structures, and Equilibrium Constants
- LAdvanced Drug Delivery Reviews 37 (1999) 189211 Utilization of metabolic, transport and receptor-mediated
- DOI: 10.1002/ejic.200500579 Kinetic Inertness and Electrochemical Behavior of Copper(II)
- Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal
- Development of a two-antibody model for the evaluation of copper-64
- Comparison of Four 64Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron
- The In Vivo Behavior of Copper-64-Labeled Azamacrocyclic Complexes
- High Purity Production and Potential Applications of Copper-60 and Copper-61
- TOXICITY AND DOSIMETRY OF 177 LU-DOTA-Y3-OCTREOTATE
- ORIGINAL ARTICLE Xiankai Sun Melinda Wuest Zoltan Kovacs
- Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution
- Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging Carolyn J. Anderson* and Michael J. Welch
- Indium(III) and Gallium(III) Complexes of Bis(aminoethanethiol) Ligands with Different Denticities: Stabilities, Molecular Modeling, and in Vivo Behavior
